Over the past ten years, GLP-1 receptor agonists (GLP-1RAs) such as Ozempic, Wegovy, and Mounjaro have taken the pharmaceutical world by storm
For them, pushing to the maximum dose is not just unnecessary
FLOW trial stopped early due to evidence of renal protection with semaglutide
The New England Journal of Medicine, 391 (2), 109121
MOTS-c is a mitochondrial-derived peptide that influences how cells use glucose and fat for energy, described as mimicking some of the metabolic effects of exercise at a cellular level, with reported benefits including increased stamina and reduced belly fat
Healthcare professionals may prescribe metformin alongside GLP-1 medication